DEA Extends Schedule I Status of Synthetic Cannabinoid Cumyl-Pegaclone for 1 Year
December 11, 2025
December 11, 2025
WASHINGTON, Dec. 11 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration has extended the temporary schedule I placement of the synthetic cannabinoid Cumyl-Pegaclone, also known as SGT-151, for an additional year, keeping the substance under the strictest level of federal control.
The extension continues the schedule I restrictions originally imposed on December 12, 2023. The classification means that anyone who manufactures, distributes, imports, exports, resea . . .
The extension continues the schedule I restrictions originally imposed on December 12, 2023. The classification means that anyone who manufactures, distributes, imports, exports, resea . . .